Regressing to the Mean: FDA Innovative Drug Approvals Drop Back to “Normal” Levels
This article was originally published in RPM Report
Executive Summary
Last year’s 39 NME approvals is not the “new normal,” Office of New Drugs Director John Jenkins declares. FDA approved just 27 NMEs in 2013. The return to normal also included a quiet December.